Edition:
United States

Medical Developments International Ltd (MVP.AX)

MVP.AX on Australia Stock Exchange

4.66AUD
23 May 2017
Change (% chg)

$0.01 (+0.22%)
Prev Close
$4.65
Open
$4.74
Day's High
$4.81
Day's Low
$4.66
Volume
13,408
Avg. Vol
38,481
52-wk High
$6.47
52-wk Low
$4.12

Latest Key Developments (Source: Significant Developments)

Medical Developments International signs distribution agreement with JSC Lancet to distribute Penthrox in Russia
Tuesday, 11 Apr 2017 06:54pm EDT 

Medical Developments International Ltd : Penthrox licensing deal for Russia . signed a new distribution agreement with JSC Lancet to distribute Penthrox in Russia .agreement includes milestone payments of A$2.3 mln.  Full Article

Medical Developments International announces deal with Kmart
Sunday, 9 Apr 2017 11:43pm EDT 

Medical Developments International Ltd :Has finalised a "core ranging" deal with Kmart for distribution of its respiratory devices in USA.  Full Article

Medical Developments International says Penthrox received second order for UK and Ireland
Wednesday, 1 Mar 2017 05:41pm EST 

Medical Developments International Ltd :Received second order for Penthrox from its partner Galen Pharmaceuticals Ltd for UK and Republic Of Ireland.  Full Article

Medical Developments International says Penthrox launched in France And Belgium
Tuesday, 7 Feb 2017 05:44pm EST 

Medical Developments International Ltd - :Penthrox has been launched in France And Belgium Via Mundipharma.  Full Article

Medical Developments International announces licensing deal for Korea
Monday, 5 Sep 2016 06:39pm EDT 

Medical Developments International Ltd : Licensing deal for Korea . Reached agreement with Bl&H Co Ltd ("Bl&H") for the exclusive distribution rights of Penthrox® in Korea . Says Bl&H expect to obtain approval and launch Penthrox in Korea during FY 2018 . Says the transaction includes upfront and milestone payments of AUD $1.2 million .  Full Article

Medical Developments International signs respiratory deal with Cardinal Health Inc
Tuesday, 9 Aug 2016 12:43am EDT 

Medical Developments International Ltd : MVP signs respiratory deal in the United States . Agreed a distribution deal with Cardinal Health Inc for distribution of "space chamber" anti-static respiratory devices in the US .  Full Article

Medical Developments International received written response to its meeting request by the FDA
Tuesday, 9 Aug 2016 12:43am EDT 

Medical Developments International Ltd : Received a written response to its meeting request by the food & drug administration (FDA) in the United States of America . Gathered clinical data to achieve approval of penthrox in United Kingdom, France, Ireland, Belgium, Singapore, South Africa and elsewhere .  Full Article

Medical Developments signs licensing deal for distribution of Penthrox in Canada
Monday, 13 Jun 2016 07:14pm EDT 

Medical Developments International Ltd : Licensing deal for Canada . The term sheet includes upfront and milestone payments of C$3.0 million . Signed a term sheet with pharmaceutical company to distribute Penthrox in Canada .  Full Article

Medical Developments signs respiratory deals in United States and Portugal
Tuesday, 24 May 2016 07:38pm EDT 

Medical Developments International Ltd : Signs respiratory deals in the United States and Portugal .  Full Article

Avita Medical sells respiratory business for $2.64m to Medical Developments International
Thursday, 24 Dec 2015 06:00am EST 

Avita Medical Ltd:Announced that it has signed an agreement to sell its respiratory business to Medical Developments International for $2.64m.  Full Article

More From Around the Web